2013
DOI: 10.1016/s1569-9056(13)60594-1
|View full text |Cite
|
Sign up to set email alerts
|

102 GTx-758, an ERα agonist, reduces serum free testosterone lower than can be achieved by leuprolide with a significantly lower rate of hot flashes in men with advanced prostate cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…This has the added effect of decreasing free testosterone even further and reducing adrenal androgens and intratumoral testosterone. 35,41-43 In a small study, Levell et al 34 assessed the relationship of total and free testosterone and survival in men with advanced prostate cancer after orchiectomy or treatment with estrogens. Although total testosterone levels were not different among groups, free testosterone levels were lower in estrogen-treated patients.…”
Section: Commentmentioning
confidence: 99%
“…This has the added effect of decreasing free testosterone even further and reducing adrenal androgens and intratumoral testosterone. 35,41-43 In a small study, Levell et al 34 assessed the relationship of total and free testosterone and survival in men with advanced prostate cancer after orchiectomy or treatment with estrogens. Although total testosterone levels were not different among groups, free testosterone levels were lower in estrogen-treated patients.…”
Section: Commentmentioning
confidence: 99%